IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
45 hedge funds and large institutions have $132M invested in Impel Pharmaceuticals Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 11 closing their positions.
Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.69%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
14
Increased
17
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$1.8M |
| 2 |
2
Two Sigma Investments
New York
|
$1.23M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$4.24M |
| 4 |
DA
4
DCF Advisers
Greenwich,
Connecticut
|
$2.21M |
| 5 |
5
BlackRock
New York
|
$3.06M |
